SEARCH

SEARCH BY CITATION

References

  • Bartik, M., Welker, D. & Kay, N. (1998) Impairments in immune cell function in B cell chronic lymphocytic leukaemia. Seminars in Oncology, 25, 2733.
  • Hamblin, T. (2001) Autoimmune disease and its management in chronic lymphocytic leukaemia. In: Chronic Lymphoid Leukaemias (ed. by B.Cheston), pp. 435458. Marcel Dekker, New York.
  • Leach, M., Parson, R.M., Reilly, J.T. & Winfield, D.A. (2000) Autoimmune thrombocytopenia: a complication of fludarabine therapy in lymphoproliferative disorders. Clinical and Laboratory Haematology, 22, 175178.
  • Maclean, R., Meiklejohn, D. & Soutar, R. (1996) Fludarabine related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia. British Journal of Haematology, 92, 768769.
  • Mynt, H., Copplestone, J.A., Orchard, J., Craig, V., Curtis, D. & Prentice, A.G. (1995) Fludarabine related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia. British Journal of Haematology, 91, 341344.
  • Stern, S., Samir, S. & Costello, C. (1999) Probable autoimmune neutropenia induced by Fludarabine therapy for chronic lymphocytic leukaemia. British Journal of Haematology, 106, 836837.